A Lower Serum Antioxidant Capacity as a Distinctive Feature for Women with HER2+ Breast Cancer: A Preliminary Study

SIMPLE SUMMARY: HER2 overexpression in breast tumors serves as a biomarker of aggressive cancer and a poor prognosis. This protein contributes to redox imbalance in the pro-oxidative sense. The study aimed to investigate the infrared spectrum wavenumbers obtained by ATR-FTIR and their relationship w...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Letícia L. D., Silva, Alinne T. F., Ferreira, Izabella C. C., Souza, Adriele V., Justino, Allisson B., Santos, Donizeti W., Goulart, Luiz Ricardo, Paiva, Carlos Eduardo, Espíndola, Foued S., Maia, Yara C. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739610/
https://www.ncbi.nlm.nih.gov/pubmed/36497455
http://dx.doi.org/10.3390/cancers14235973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739610/
https://www.ncbi.nlm.nih.gov/pubmed/36497455
http://dx.doi.org/10.3390/cancers14235973

Ejemplares similares